Rifaximin for the Secondary Prevention of Spontaneous Bacterial Peritonitis Recurrence in Cirrhotic Patients
Status:
Withdrawn
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate whether long-term rifaximin administration reduces
spontaneous bacterial peritonitis recurrence rate in cirrhotic patients.